◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
BIOCYTOGEN PHARMACEUTICALS (BEI — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 980.0M 717.0M 534.0M 355.0M 254.0M
Revenue Growth % 36.7% 34.3% 50.4% 39.8% --
Total Revenue 980.0M 717.0M 534.0M 355.0M 254.0M
Cost Of Revenue 219.0M 211.0M 142.0M 107.0M 86.5M
+Gross Profit 761.0M 506.0M 392.0M 248.0M 167.5M
Gross Margin % 77.7% 70.6% 73.4% 69.9% 65.9%
Total Operating Cost 930.0M 1.1B 1.2B 924.0M 759.0M
Selling Expenses 93.0M 62.8M 50.2M 42.0M 31.7M
Admin Expenses 187.0M 266.0M 255.0M 181.0M 240.0M
Rd Expenses 324.0M 474.0M 699.0M 558.0M 276.0M
Finance Expenses 77.8M 81.7M 26.8M 29.1M 119.0M
+Operating Income 44.5M -377.0M -601.0M -545.0M -475.0M
Operating Margin % 4.5% -52.6% -112.5% -153.5% -187.0%
Non Operating Income 229,100 117,200 121,900 135,500 44,200
Non Operating Expenses 1.8M 3.3M 313,500 856,700 1.3M
Investment Income -29.6M -297,500 8.2M 225,400 3.4M
Fair Value Change Income 13.7M 5.0M 23.2M 11.3M 22.1M
Asset Disposal Income -5,000 2.1M 3,300 778,700 --
Asset Impairment Loss 6.1M 9.4M 3.4M 1.8M 2.6M
Other Income 9.8M 11.4M 15.1M 12.6M 4.6M
Income Before Tax 42.9M -380.0M -601.0M -546.0M -477.0M
Income Tax 9.4M 2.8M 804,000 -- --
+Net Income 33.5M -383.0M -602.0M -546.0M -477.0M
Net Margin % 3.4% -53.4% -112.7% -153.8% -187.8%
Net Income Attributable 33.5M -383.0M -602.0M -546.0M -428.0M
Minority Interest -4,900 -1,000 -212,200 -66,500 -48.6M
Eps Basic 0.08 -0.96 -1.58 -1.51 -1.68
Eps Diluted 0.08 -0.96 -1.58 -1.51 -1.68
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 404.0M 418.0M 627.0M 466.0M 750.0M
Accounts Receivable 229.0M 142.0M 108.0M 103.0M 67.2M
Notes Receivable 159,900 178,800 -- -- --
Notes And Accounts Receivable 230.0M 142.0M 108.0M 103.0M 67.2M
Prepayments 8.9M 9.9M 27.6M 28.4M 25.8M
Inventory 110.0M 98.0M 108.0M 96.4M 54.9M
Total Current Assets 817.0M 723.0M 919.0M 874.0M 1.1B
Long Term Equity Investment 159.0M 188.0M 198.0M 9.7M 10.1M
Fixed Assets 1.1B 1.1B 983.0M -- 782.0M
Fixed Assets Total 1.1B 1.1B 983.0M 962.0M 782.0M
Construction In Progress 1.7M 2.4M 263.0M -- 188.0M
Construction In Progress Total 1.7M 2.4M 263.0M 175.0M 188.0M
Intangible Assets 61.1M 69.7M 73.4M 49.9M 47.4M
Long Term Deferred Expenses 96.3M 137.0M 92.0M 124.0M 19.9M
Total Non Current Assets 1.6B 1.7B 1.9B 1.4B 1.2B
Total Assets 2.4B 2.4B 2.8B 2.3B 2.3B
Short Term Borrowings 181.0M 156.0M 120.0M -- --
Accounts Payable 69.7M 115.0M 106.0M 53.9M 34.8M
Contract Liabilities 102.0M 69.2M 56.4M 61.6M 47.5M
Total Current Liabilities 535.0M 578.0M 606.0M 447.0M 328.0M
Long Term Borrowings 156.0M 129.0M -- -- --
Total Non Current Liabilities 1.0B 1.1B 1.0B 604.0M 540.0M
Total Liabilities 1.6B 1.7B 1.6B 1.1B 868.0M
Paid In Capital 399.0M 399.0M 399.0M 375.0M 360.0M
Capital Reserve 2.2B 2.2B 2.2B 1.7B 1.4B
Retained Earnings -1.8B -1.8B -1.4B -802.0M -257.0M
Minority Equity 4.5M 4.5M 4.6M 4.8M 4.8M
Equity Attributable 834.0M 786.0M 1.1B 1.2B 1.5B
Total Equity 839.0M 790.0M 1.2B 1.3B 1.5B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 978.0M 744.0M 576.0M 345.0M 241.0M
Tax Refunds Received 819,100 6.5M 63.0M 48.3M 6.6M
Total Operating Cash Inflow 992.0M 774.0M 655.0M 416.0M 262.0M
Cash Paid For Goods 320.0M 312.0M 438.0M 395.0M 228.0M
Cash Paid To Employees 313.0M 388.0M 422.0M 294.0M 191.0M
Taxes Paid 34.9M 11.2M 4.3M 3.4M 2.1M
Total Operating Cash Outflow 781.0M 851.0M 958.0M 782.0M 492.0M
Operating Cash Flow 211.0M -76.6M -303.0M -366.0M -231.0M
Total Investing Cash Inflow 9.8M 26.3M 103.0M 655.0M 1.4B
Total Investing Cash Outflow 147.0M 127.0M 257.0M 739.0M 1.6B
Investing Cash Flow -137.0M -100.0M -154.0M -84.1M -183.0M
Cash From Borrowings 236.0M 320.0M 150.0M -- --
Dividends And Interest Paid 15.2M 5.0M 4.1M -- --
Debt Repayments 177.0M 146.0M 30.0M -- 16.9M
Total Financing Cash Inflow 239.0M 320.0M 731.0M 311.0M 948.0M
Total Financing Cash Outflow 331.0M 358.0M 143.0M 91.6M 79.9M
Financing Cash Flow -92.0M -37.8M 587.0M 219.0M 868.0M
Net Change In Cash -15.1M -211.0M 144.0M -231.0M 451.0M
Ending Cash Balance 384.0M 400.0M 611.0M 466.0M 697.0M
Capex 37.1M 127.0M 240.0M 199.0M 296.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...